These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17277138)

  • 1. Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation.
    Al-Alwan MM; Okkenhaug K; Vanhaesebroeck B; Hayflick JS; Marshall AJ
    J Immunol; 2007 Feb; 178(4):2328-35. PubMed ID: 17277138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bam32/DAPP1 promotes B cell adhesion and formation of polarized conjugates with T cells.
    Al-Alwan M; Hou S; Zhang TT; Makondo K; Marshall AJ
    J Immunol; 2010 Jun; 184(12):6961-9. PubMed ID: 20495066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development.
    Ramadani F; Bolland DJ; Garcon F; Emery JL; Vanhaesebroeck B; Corcoran AE; Okkenhaug K
    Sci Signal; 2010 Aug; 3(134):ra60. PubMed ID: 20699475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of antigen presentation and B cell receptor signaling in B cells of beige mice.
    Chatterjee P; Tiwari RK; Rath S; Bal V; George A
    J Immunol; 2012 Mar; 188(6):2695-702. PubMed ID: 22327079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell receptor signaling: picky about PI3Ks.
    Limon JJ; Fruman DA
    Sci Signal; 2010 Aug; 3(134):pe25. PubMed ID: 20699473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells.
    Bilancio A; Okkenhaug K; Camps M; Emery JL; Ruckle T; Rommel C; Vanhaesebroeck B
    Blood; 2006 Jan; 107(2):642-50. PubMed ID: 16179367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathway of antigen uptake and processing dictates MHC class II-mediated B cell survival and activation.
    Nashar TO; Drake JR
    J Immunol; 2005 Feb; 174(3):1306-16. PubMed ID: 15661887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes.
    Glassford J; Vigorito E; Soeiro I; Madureira PA; Zoumpoulidou G; Brosens JJ; Turner M; Lam EW
    Eur J Immunol; 2005 Sep; 35(9):2748-61. PubMed ID: 16114097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin-binding protein 1 regulates B cell receptor-mediated antigen processing and presentation in response to B cell receptor activation.
    Onabajo OO; Seeley MK; Kale A; Qualmann B; Kessels M; Han J; Tan TH; Song W
    J Immunol; 2008 May; 180(10):6685-95. PubMed ID: 18453588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC; Steele CR; Gu L; Song W; Pierce SK
    J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human B Cells Engage the NCK/PI3K/RAC1 Axis to Internalize Large Particles via the IgM-BCR.
    Verstegen NJM; Unger PA; Walker JZ; Nicolet BP; Jorritsma T; van Rijssel J; Spaapen RM; de Wit J; van Buul JD; Ten Brinke A; van Ham SM
    Front Immunol; 2019; 10():415. PubMed ID: 30930895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
    Okkenhaug K; Bilancio A; Farjot G; Priddle H; Sancho S; Peskett E; Pearce W; Meek SE; Salpekar A; Waterfield MD; Smith AJ; Vanhaesebroeck B
    Science; 2002 Aug; 297(5583):1031-4. PubMed ID: 12130661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses.
    Hess KL; Donahue AC; Ng KL; Moore TI; Oak J; Fruman DA
    Eur J Immunol; 2004 Nov; 34(11):2968-76. PubMed ID: 15384044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p110δ phosphoinositide 3-kinase represses IgE switch by potentiating BCL6 expression.
    Zhang TT; Makondo KJ; Marshall AJ
    J Immunol; 2012 Apr; 188(8):3700-8. PubMed ID: 22422878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease.
    Maxwell MJ; Tsantikos E; Kong AM; Vanhaesebroeck B; Tarlinton DM; Hibbs ML
    J Autoimmun; 2012 Jun; 38(4):381-91. PubMed ID: 22537464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Btk regulates B cell receptor-mediated antigen processing and presentation by controlling actin cytoskeleton dynamics in B cells.
    Sharma S; Orlowski G; Song W
    J Immunol; 2009 Jan; 182(1):329-39. PubMed ID: 19109164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation.
    Beer-Hammer S; Zebedin E; von Holleben M; Alferink J; Reis B; Dresing P; Degrandi D; Scheu S; Hirsch E; Sexl V; Pfeffer K; Nürnberg B; Piekorz RP
    J Leukoc Biol; 2010 Jun; 87(6):1083-95. PubMed ID: 20200404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ig alpha and Ig beta are required for efficient trafficking to late endosomes and to enhance antigen presentation.
    Siemasko K; Eisfelder BJ; Stebbins C; Kabak S; Sant AJ; Song W; Clark MR
    J Immunol; 1999 Jun; 162(11):6518-25. PubMed ID: 10352267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
    Durand CA; Richer MJ; Brenker K; Graves M; Shanina I; Choi K; Horwitz MS; Puri KD; Gold MR
    Autoimmunity; 2013 Feb; 46(1):62-73. PubMed ID: 23039284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
    Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
    J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.